ARALEZ PHARMACEUTICALS INC. Financing Cash Flow
ARALEZ PHARMACEUTICALS INC. reported Financing Cash Flow of -$3.37 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2018-05-08
- ARALEZ PHARMACEUTICALS INC. net cash provided by (used in) financing activities for the quarter ending 2018-03-31 was -$3.37M.
- ARALEZ PHARMACEUTICALS INC. net cash provided by (used in) financing activities for the quarter ending 2017-12-31 was -$2.20M, a 101.10% decline year-over-year.
- ARALEZ PHARMACEUTICALS INC. net cash provided by (used in) financing activities for the quarter ending 2017-09-30 was -$160.00K, a 119.25% decline year-over-year.
- ARALEZ PHARMACEUTICALS INC. net cash provided by (used in) financing activities for the quarter ending 2017-06-30 was -$3.85M.
- ARALEZ PHARMACEUTICALS INC. net cash provided by (used in) financing activities for fiscal 2017 was -$6.23M, a 101.80% decline from fiscal 2016.
- ARALEZ PHARMACEUTICALS INC. net cash provided by (used in) financing activities for fiscal 2016 was $346.26M.
- ARALEZ PHARMACEUTICALS INC. net cash provided by (used in) financing activities for fiscal 2015 was -$1.22M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2018-03-31 | -$3.37M 10-Q · filed 2018-05-08 | -$5.57M derived: sum of 2 quarters · filed 2018-05-08 | -$5.73M derived: sum of 3 quarters · filed 2018-05-08 | -$9.58M derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-12-31 | -$2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | -$2.36M derived: sum of 2 quarters · filed 2018-03-14 | -$6.22M derived: sum of 3 quarters · filed 2018-03-14 | -$6.23M 10-K · filed 2018-03-14 |
| 2017-09-30 | -$160.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$4.01M derived: sum of 2 quarters · filed 2017-11-09 | -$4.03M 10-Q · filed 2017-11-09 | $196.49M derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-06-30 | -$3.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$3.87M 10-Q · filed 2017-08-09 | $196.65M derived: sum of 3 quarters · filed 2018-05-08 | $197.48M derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-03-31 | -$17.00K 10-Q · filed 2018-05-08 | $200.50M derived: sum of 2 quarters · filed 2018-05-08 | $201.33M derived: sum of 3 quarters · filed 2018-05-08 | |
| 2016-12-31 | $200.52M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $201.35M derived: sum of 2 quarters · filed 2018-03-14 | $346.26M 10-K · filed 2018-03-14 | |
| 2016-09-30 | $831.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $145.74M 10-Q · filed 2017-11-09 | ||
| 2016-06-30 | $144.91M 10-Q · filed 2017-08-09 | |||
| 2015-12-31 | -$1.22M 10-K · filed 2018-03-14 |